Zynerba Pharmaceuticals, Inc.
Treatment of autism with cannabidiol
Last updated:
Abstract:
The present technology relates to a method of treating one or more behavioral symptoms of Autism Spectrum Disorder (ASD) in a subject by transdermally administering an effective amount of cannabidiol (CBD) to the subject wherein one or more behavioral symptoms of ASD are treated in the subject.
Status:
Grant
Type:
Utility
Filling date:
14 May 2019
Issue date:
25 Feb 2020